Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 90Triple Negative Breast Neoplasms 18Stomach Neoplasms 14Inflammatory Breast Neoplasms 12Esophageal Neoplasms 7Lymphoma, Large B-Cell, Diffuse 5Testicular Neoplasms 3Pancreatic Neoplasms 3Lymphoma 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Carcinoma, Hepatocellular 2Carcinoma, Adenoid Cystic 2Breast Neoplasms, Male 2pCR Rate 1Women With Primary Breast Cancer 1Upper Tract Urothelial Carcinoma 1Unilateral HER2 Positive Breast Cancer 1Thymoma 1Testicular Germ Cell Tumor 1Small Cell Lung Cancer Extensive Stage 1Rare Tumour 1Prostatic Neoplasms 1Primary Breast Cancer 1

Interventions

Zoledronic Acid 1Trastuzumab 1Mastectomy, Segmental 1Mastectomy, Modified Radical 1Epirubicin 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Micrometastasis × Epirubicin × Clear all
NCT00242203 2013-08-13

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Washington University School of Medicine

Phase 2 Completed
120 enrolled
Breast

Breast Neoplasms, Neoplasm Micrometastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡